The pre-clinical development news monitor, with emphasis on commercial and academic R&D programs, scientific breakthroughs in drug discovery, proof-of-principle data, and the growing bridge between research and clinical proof-of-concept studies.
Audience:   Pre-clinical scientists, lab directors, and corporate leadership early stage drug developers.

Key Topics: Commercial and academic R&D programs, scientific breakthroughs in drug discovery, R&D trends and financing, stem cell news, preclinical research, the growing bridge between research and clinical proof-of-concept studies

Newsletter Frequency: Weekly

Email Subscribers: 43,000+

Monthly page views: 22,000

Reader Demographics

Company Type
Pharmaceutical - 25%
Biotechnology - 24%
CRO/CMO/Contract Outsourcing - 19%
Healthcare/Medical - 5%
IT/IS/Bioinformatics - 3%
Instruments/Materials - 3%
Financial/Legal - 3%
Devices/Diagnostics - 2%
Marketing / Ad Agency - 2%
Government - 1%
Other - 13%

Job Function
CEO / C-Level Executive - 21%
R&D / Engineering - 17%
Clinical Operations - 12%
Licensing / Biz Dev - 9%
Sales - 6%
Finance / Legal - 6%
Marketing / Brand Mgmt - 5%
Manufacturing / Packaging - 3%
Regulatory / Compliance / Safety - 3%
IT / IS / Bioinformatics - 2%
QA / QC - 2%
Medical Affairs - 2%
Other - 12%

Region
North America - 68%
Europe - 11%
Asia - 12%
Australia/NZ - 1%
Other - 8%

View Rates

Enter your contact information to see current rates and packages.

Top Companies Represented

Abbott Bioresearch
Amgen
Allergan
Applied Biosystems
Array Biopharma
AstraZeneca
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Centocor
Cephalon
Charles River Laboratories
Columbia University
Covance
Elan Pharmaceuticals
Eli Lilly
EnVivo Pharmaceuticals
Exelixis
Fisher Scientific
Genentech
Genzyme
GlaxoSmithKline
Harvard Medical School
Health Advances
Invitrogen
Johnson & Johnson
Lexicon Genetics
Medarex
MedImmune
Merck & Co.
Millipore
NIH
Pfizer
Roche
Sanofi-Aventis
Stanford University
Theravance, Inc.
Wyeth Research